MGTX (MeiraGTx Corp) Sotuvning sof marjinal rentabelligi

MeiraGTx (MGTX) korporativ emblemasi va logotipi

MeiraGTx Holdings plc (MGTX) genetik modifikatsiya sohasida yetakchi sifatida tan olingan va biomeditsina mutaxassislari orasida nufuz qozongan. Kompaniyaning shaxsiy vektor ishlab chiqarish zavodlari dori vositalarini ishlab chiqish jarayonidagi xatarlarni minimallashtirish orqali firmaning mavqeini mustahkamlaydi. Daromadlar neyrodegenerativ patologiyalar va retinal kasalliklar uchun terapiyalarga asoslangan. Moliyaviy savdo marjalari kapital samaradorligini namoyish etadi, 19.50 ko'rsatkichi esa joriy aktivlar rentabelligi holatini aks ettiradi.

MeiraGTx Holdings plc (MGTX) - Kompaniya sotuv marjasi 04.07.2022dan 20.11.2026gacha

MeiraGTx Corp (MGTX) kompaniyasi koʻrsatkichlari kesimi va tahlili

- bozor qiymati va tahlilchilarning maqsadli prognozi:
- biznesning bozor baholash ko'rsatkichlari:
Kompaniyaning barcha koʻrsatkichlari tahlili:MeiraGTx, MGTX
MeiraGTx PLC yetakchi tovari

MeiraGTx Holdings plc (MGTX) kompaniyasining operatsion pasayishlarga bardosh berish qobiliyati barqaror savdoning yo'qligi va gen terapiyasi hamkorlaridan keladigan beqaror to'lovlarga bog'liqlik tufayli cheklangan. Yillik sof marja uchun 19.50 ning joriy qiymati barcha xarajatlardan keyin qolgan daromad qismini aks ettiradi, bu esa investorlarga biznesning haqiqiy samaradorligini baholash imkonini beradi; biroq, yakuniy xulosa chiqarish uchun ushbu ma'lumotlar kapital qiymati bilan solishtirilishi kerak.

MeiraGTx Holdings plc kimlar bilan raqobatlashadi

TEM: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Repligen Inc. - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi RNA|CRSP - Sof marja|GeneDx - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi RARE|Beam Tx - Sotuvning sof marjinal rentabelligi|SRPT - Sotuvning sof marjinal rentabelligi|TWST (Twist Bio) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi TXG|Sof foyda bo'yicha sotuv rentabelligi NTLA|Stoke Therapeutics Inc (STOK) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi BLFS|Sof marja WVE (Wave Life Sciences Corp)|Sof marja Maze Therapeutics MAZE|Sof foyda normasi SION|PRME - Sof marja|Kompaniya sotuv marjasi Taysha TSHA|QURE: Sotuvning sof marjinal rentabelligi|Regenxbio - Sof foyda normasi|Sof marja solidbio.com|Sof marja ocugen.com OCGN|Sotuvning sof marjinal rentabelligi PACB|Benitec - Sotuvning sof rentabelligi|Sof marja Design Therapeutics DSGN|Sotuvning sof marjinal rentabelligi Rocket Pharmaceuticals RCKT|Sof foyda marjasi 4D Molecular Corp|LXEO: Sof marja|KRRO (Korro Bio, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Editas Medicine (EDIT) - Sotuvning sof marjinal rentabelligi|Sof marja Silence Therapeutics Inc.|Sotuvning sof rentabelligi PRQR (proqr.com)|Sof marja Codexis Bio (CDXS)|Sotuvning sof marjinal rentabelligi sangamo.com (SGMO)|Sof marja nautilus.bio NAUT|Kompaniya sotuv marjasi Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Sotuvning sof marjinal rentabelligi|GBIO - Sotuvning sof marjinal rentabelligi|BOLD: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi XCUR|Sof marja Imunon|Phio Pharmaceuticals - Sof foyda marjasi|Sof marja Mustang Bio, Inc. (MBIO)|Kompaniya sotuv marjasi TransCode Therapeutics, Inc.|Sof marja Bionano Genomics BNGO|Sof foyda normasi APDN|BLUE - Sof marja|Sof foyda marjasi IPA|Omega Therapeutics, Inc. (OMGA) - Sof marja|Singular Genomics Corp (OMIC) - Sotuvning sof marjinal rentabelligi|RGLS (Regulus Therapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|SYRS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX